The Broad Institute's David Sabatini and colleagues report in Nature on their development and use of a method to uncover novel cancer targets. Their method uses a negative-selection RNAi screen that they then applied to find metabolic genes that are necessary for tumorigenesis in breast cancer.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.